Please assess the completion status of the following clinical trial:

Trial Title: Early Rabies Vaccine Immunization in Primary School Children

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~Male and female 5-8 years old school children will be included in the study if:~* Their parents or legal guardians have given the written informed consent prior to study entry;~* They are in good health at time of study entry as determined by medical history, physical examination and clinical judgment of the investigator;~* They are available for all the visits scheduled in the study.~Exclusion criteria:~Subjects are not to be enrolled into the study if:~* They have a history of rabies immunization;~* They have an acute infectious disease at the time of study entry;~* They are under treatment with parenteral and/or oral steroids, immunosuppressive drugs, phenytoin or other specific anti-inflammatory drugs, or have taken chloroquine during the two month period before enrolment;~* They have a known immunodeficiency or an autoimmune disease;~* They have a known hypersensitivity to neomycin, tetracycline or amphotericin-B;~* They have planned surgery during the first study period (49 days);~* They are participating in any other trial of an investigational agent;~* They have any condition which in the opinion of the investigator, might interfere with the evaluation of the study objectives.~* The family plans to leave the area of the study site before the end of the study period.

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 8 Years
- Healthy Volunteers: t

Study Arms:
- 2 primary ID doses (Type: EXPERIMENTAL): two doses of rabies vaccines given intradermally on days 0 and 28
- 3 primary ID doses (Type: EXPERIMENTAL): three doses of rabies vaccines given intradermally on days 0, 7, and 28

Based on this trial design, predict the completion outcome and termination type (if applicable).